New Imaging-Guided biopsy aims to improve breast cancer detection
NCT ID NCT04862429
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using contrast-enhanced mammography to guide breast biopsies is more accurate than the standard X-ray-guided method for suspicious calcifications. About 184 women with suspicious calcifications (BIRADS R3-R5) were randomly assigned to one of the two biopsy techniques. The goal was to see if the new method better targets the most dangerous part of the lesion, potentially improving diagnosis and treatment planning.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
contrast-enhanced mammography guided biopsy
What this could lead to
If successful, this could make breast biopsies more accurate, reducing the need for repeat procedures and improving detection of aggressive cancers.
What could go wrong
This is a completed, moderate-sized study. The technique requires contrast dye, which carries a small risk of allergic reaction or kidney issues. It may not be widely available or change standard practice if results are not clearly superior.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda USL - IRCCS di Reggio Emilia
Reggio Emilia, RE, 42123, Italy